Anthony Murabito
About Anthony Murabito
Anthony Murabito serves as the Vice President of Information Technology at Wave Life Sciences, where he has led the development of critical informatics platforms since 2018. He possesses extensive experience in the pharmaceutical and biotech sectors, having held various leadership roles in IT and information management across multiple organizations.
Work at Wave Life Sciences
Anthony Murabito has served as Vice President of Information Technology at Wave Life Sciences since 2018. In this role, he has led the development of the company's Discovery informatics platform and high-performance compute environments tailored for Data Sciences, Bioinformatics, and Biopharmaceuticals. He completed a significant refresh of the Wave information and security environment by deploying a rearchitected system. Additionally, he delivered an IT governance framework that includes computer system validation to support Wave's cloud and GXP environments.
Education and Expertise
Anthony Murabito's educational background includes a Master of Science in Health/Health Care Administration/Management from Widener University, completed from 1981 to 1983. He studied Pharmacy at the University of the Sciences in Philadelphia, earning his RPh from 1975 to 1981. He also attended Drexel University for one year in 1979, focusing on Business. His foundational education was at St Joseph's Prep from 1971 to 1975.
Professional Background
Anthony Murabito has held various significant roles in the pharmaceutical and biotechnology sectors. Prior to his current position, he worked at Aralez Pharmaceuticals as Global Head of IT from 2015 to 2018. He served as Executive Director at Boston Biomedical for one year in 2014-2015. His earlier experience includes positions at Cubist Pharmaceuticals as CIO and VP of Information and Business Solutions from 2003 to 2011, and at Human Genome Sciences as VP and CIO from 2011 to 2012.
Previous Roles and Contributions
Before joining Wave Life Sciences, Anthony Murabito worked at Guidepoint Global as an Independent Pharmaceutical & Biotech Consultant from 2013 to 2014. He held roles at SmithKline Beecham, including Group Director of Global R&D Information Management from 1993 to 2000 and Director of Product Information and Professional Services from 1989 to 1993. He developed and delivered a commercial information architecture in anticipation of Duchenne Muscular Dystrophy (DMD) success during his tenure.